The Healthcare Policy Podcast ® Produced by David Introcaso Rosemary Gibson Discusses Her Recent Work, "China Rx" (December 7th)
During this 31 minute discussion Rosemary Gibson unpacks her latest work, co-authored with Janardan Prasad Singh, titled, China, Rx, "Exposing the Risks of America's Dependence on China For Medicine. As the title suggests the authors discuss the problems with relying on China for the production of essential ingredients for thousands of medicines, or the implications of relying on China regarding the quality and availability of essential drugs.
Rosemary Gibson is Senior Adviser at The Hastings Center. She is also board chair of the Altarum Institute, a non-profit health system research organization, she is a board member of the Accreditation Council for Graduate Medical Education, she serves on the MedStar Health System Institute for Quality and Patient Safety advisory board, is faculty for the Academy for Emerging Health Care Leaders and for the Dartmouth Summer Symposium on Quality Improvement. While at the Robert Wood Johnson Foundation, Rosemary was the chief architect for it's $250 million, decade-long national strategy to establish inpatient palliative care programs that now number over 1,600. She is also author of Medicare Meltdown (2013), Battle Over Health Care (2012), Treatment Trap (2010) and Wall of Silence (2003). Among other awards, Rosemary is the recipient of highest honors from the American Medical Writers Association for her contributions to the field of medical communication.
Information on China Rx is at: https://www.penguinrandomhouse.com/books/566043/china-rx-by-rosemary-gibson-and-janardan-prasad-singh/9781633883819/
This is a public episode. If you would like to discuss this with other subscribers or get access to bonus episodes, visit www.thehealthcarepolicypodcast.com